Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 169-180 of 2,031
Drug study icon
RecruitingNCT06488586

IV Ketamine vs. IN Esketamine for MDD TRD

This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Kingston
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
Canada
Sponsor
Gustavo Vazquez
Condition
Depression
Device study icon
RecruitingNCT07230990

Mechanisms Of Orbitofrontal Stimulation in Depression

This study is looking at care and outcomes for people with depression. Some participants may receive Sham OFC stimulation instead of the study treatment, and direct benefit is not guaranteed.

In Boston
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Subha Subramanian
Condition
Depression
Device study icon
RecruitingNCT05661383

Olfactory and Brain Stimulations in Treatment-resistant Depression

This study is looking at whether a digital support tool can help people with Treatment-resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.

In Bron
Why is this study shown?

This study is directly about Depression.

DepressionDeviceOver 18 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression
Device study icon
RecruitingNCT04124341

PCS in Severe Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Minneapolis
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Depression
Drug study icon
RecruitingNCT06788249

Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

This study is looking at whether Ketamine only can help people with depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Philadelphia
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 25 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Drug study icon
RecruitingNCT06378229

Psilocybin for Hospitalized people with Treatment-resistant Depression

This study is looking at determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression for people with Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Ghent
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
Belgium
Sponsor
University Hospital, Ghent
Condition
Depression
Drug study icon
RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
RecruitingNCT07216404

Psilocybin-Assisted Therapy for Major Depressive Disorder in people with Non-Small Cell Lung Cancer

This study is looking at whether questionnaires and follow-up can help people with Lung Non-Small Cell Carcinoma or Unipolar Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Columbus
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Alan Davis
Condition
Depression
Behavioral study icon
RecruitingNCT05833087

Schema Therapy for people with Chronic Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or Chronic Depression. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Ballerup Municipality
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
Region of Southern Denmark
Condition
Depression
Device study icon
RecruitingNCT05607654

The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression

This study is looking at care and outcomes for people with Treatment-resistant Depression. Some participants may receive sham rTMS instead of the study treatment, and direct benefit is not guaranteed.

In Hangzhou
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 45 Years
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Condition
Depression
Device study icon
RecruitingNCT03952962

Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or Undergoing Deep Brain Stimulation Surgery. Participants take part in a digital support tool and complete follow-up assessments.

In Dallas
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 21 Years to 70 Years
Countries
United States
Sponsor
Nader Pouratian
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.